Universities, companies and research centres have sent more than 15,000 ideas for European research projects to the European Commission. More than 100,000 groups and institutions were involved in drafting the ideas; the proposed teams involve potentially several hundreds of thousands of researchers across Europe and beyond. In a radical departure from previous programmes and for the first time, on March 20, 2002, the Commission asked the scientific community to say what they see as the most promising topics for cutting edge research in the 6th Research Framework Programme, due to be launched in autumn this year. Research Commissioner Philippe Busquin is encouraged by the massive response. "It shows that the European Research Area is becoming a reality", he said. "The strong response also demonstrates that our researchers have many good ideas. That much more funding for research is needed in Europe through a co-ordinated investment by Member States. It is an encouraging sign as we work towards the EUs target of investing 3% of GDP in research by 2010. Our researchers want to work together and share efforts with the best of their field in other countries. They want to work together in a new way at the European level, namely in projects or networks with sufficient critical mass to meet global scientific or technological challenges."
Encouraging closer links between researchers all over the EU is a key priority for the European Commission. EU action to pool resources, to bring together research teams in different countries and to share expertise is essential if the EU is to compete both scientifically and economically in the global marketplace. Without EU action, compartmentalisation of EU member states research efforts, duplication of research efforts and failure to share expertise would continue to undermine EU competitiveness.
The European Parliament and the European Council decided earlier this month on the main orientations of the 6th Framework Programme, which will have a 4-year budget of EUR 17,5 billion. The Commission invited companies, universities and research centres to express their interest for research projects or networks in the fields of genomics and life sciences, information technologies, nanotechnologies, aerospace, food safety, sustainable development and social sciences. Submissions are split roughly equally between integrated projects and networks of excellence, the new modes of working in the European research programmes.
In an effort to promote partnering and collaboration, the Commission will publish all expressions of interest over the summer on a dedicated web site. An analysis of the ideas received will be made public in September 2002 and will feed into the drafting of the detailed work programmes, which form the basis for the calls for proposals to be published at the end of this year.
The Sixth EU Framework Programme for Research and Development will run from 2002 to 2006. It is designed as an instrument to help realise a European Research Area, an objective initially set by the European Commission and endorsed by the Heads of state and government at their spring summits. The new Framework Programme is based on 4 main principles: promoting scientific excellence, concentrating on a limited number of priorities with a true European added value, structuring and integrating European and national efforts, and simplifying procedures.
Fabio FABBI: 02 2964174
Lone MIKKELSEN : 02 2960567
Fabio Fabbi | EU Commission
Magnetic nanopropellers deliver genetic material to cells
08.05.2020 | Max-Planck-Institut für Intelligente Systeme
Development of new system for combatting COVID-19 that can be used for other viruses
08.04.2020 | University of Texas Medical Branch at Galveston
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
27.05.2020 | Information Technology
27.05.2020 | Physics and Astronomy
27.05.2020 | Earth Sciences